Clinical trial
A Multi-center, Phase 2 Study Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC in Combination With tPA, Mechanical Thrombectomy or Both in Moderate to Severe Acute Ischemic Stroke
NCT02222714 is registered in ClinicalTrials.gov with ZZ Biotech, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Phase 2 Study Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC in Combination With tPA, Mechanical Thrombectomy or Both in Moderate to Severe Acute Ischemic Stroke
- Lead sponsor
- ZZ Biotech, LLC
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- June 29, 2017
- Enrollment
- 110 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.